Salix Pharmaceuticals, Ltd. objective is to be a market-driven specialtypharmaceutical company focussed on the needs of physicians specializing ingastroenterology. The company intends to establish a small direct sales force to promote its products to this specialist audience. The company's strategy is to identify and acquire products that have near-term commercial potential and apply its regulatory and product development expertise to commercialize these products. The company selects products that it believes serve a gastrointestinal disease. Salix Pharmaceuticals Ltd. has a market cap of $1.15 billion; its shares were traded at around $23.59 with and P/S ratio of 6.4.
Insiders' Positions with SLXP
- Sell:: President & CEO Carolyn J Logan sold 10,000 shares of SLXP stock on 09/14/2009 at the average price of 20.67, the price of the stock has increased by 14.13% since
- Sell:: President & CEO Carolyn J Logan sold 10,000 shares of SLXP stock on 09/14/2009 at the average price of 20.67, the price of the stock has increased by 14.13% since
Insiders' Positions with SLXP
- Sell:: EVP Finance/CFO Adam C Derbyshire sold 5,000 shares of SLXP stock on 11/11/2009 at the average price of 20.12, the price of the stock has increased by 17.25% since
- Sell:: EVP Finance/CFO Adam C Derbyshire sold 5,000 shares of SLXP stock on 11/04/2009 at the average price of 19.7, the price of the stock has increased by 19.75% since
- Sell:: EVP Finance/CFO Adam C Derbyshire sold 5,000 shares of SLXP stock on 10/28/2009 at the average price of 19.79, the price of the stock has increased by 19.2% since
- Sell:: EVP Finance/CFO Adam C Derbyshire sold 5,000 shares of SLXP stock on 10/21/2009 at the average price of 21, the price of the stock has increased by 12.33% since
- Sell:: EVP Finance/CFO Adam C Derbyshire sold 5,000 shares of SLXP stock on 10/14/2009 at the average price of 22.89, the price of the stock has increased by 3.06% since
Insiders' Positions with SLXP
- Buy:: Director Mark A Sirgo bought 950 shares of SLXP stock on 08/14/2009 at the average price of 12.46, the price of the stock has increased by 89.33% since
- Sell:: James E Flynn sold 1,025,953 shares of SLXP stock on 09/10/2009 at the average price of 13.09, the price of the stock has increased by 80.21% since
- Sell:: James E Flynn sold 80,921 shares of SLXP stock on 08/19/2009 at the average price of 12.96, the price of the stock has increased by 82.02% since
- Sell:: Director Richard A Franco sold 5,200 shares of SLXP stock on 08/14/2009 at the average price of 12.57, the price of the stock has increased by 87.67% since
- Sell:: James E Flynn sold 357,612 shares of SLXP stock on 07/29/2009 at the average price of 13, the price of the stock has increased by 81.46% since
Become a Premium Member to See This: (Free Trial):
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
Rate This Article: |
  |